FLUOROSINDAN 250mg/5ml solution for injection / infusion ACTAVIS
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Find medicines for human use by name or active substance.
Browse by initial
561–580 of 836 medicines
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: flupirtine
N02BG07 Nervous system | Other analgesics and antipyretics
Indicated for: moderate to severe pain
Active substance: fluorouracil
L01BC02 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: cancer
Active substance: fluoxetine
N06AB03 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression
Active substance: salmeterol + fluticasone
Indicated for: asthma; chronic obstructive pulmonary disease
Active substance: salmeterol + fluticasone
Indicated for: asthma; chronic obstructive pulmonary disease
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.